Related Experiment Video
Updated: Jun 25, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Palliative Care for Children and Adolescents with Non-curative Brain Tumors: A Scoping Review
Marmareen Bakhtary1, Pragati Sharma2,3,4, Sarah Raspin5
1Melbourne Medical School, The University of Melbourne, Melbourne, Australia.
Insights
Palliative care for children with non-curative brain tumors lacks international standards, leading to inconsistent care. Developing standardized models, including early integration and multidisciplinary support, is crucial for improving quality of life.
Area of Science:
- Pediatric Oncology
- Palliative Care
- Neurology
Background:
- Children with non-curative brain tumors experience progressive neurological decline.
- Care coordination is challenging between acute services and community providers.
- Timely access to specialist palliative care is essential for these children.
Purpose of the Study:
- To explore evidence on palliative care standards, guidelines, and models for children with non-curative brain tumors.
- To identify facilitators and barriers to implementing and accessing these services.
Main Methods:
- A scoping review using narrative synthesis.
- Searched six electronic databases (January 2013 - May 2023).
- Screened 2404 studies, selecting 31 for data extraction.
Main Results:
- No international models or standards for pediatric palliative care in non-curative brain tumors were identified.
- Palliative care delivery is institutional, resulting in care variability.
- This variability impacts the quality of life for affected children and families.
Conclusions:
- Standardized palliative care provision is needed to minimize care variability.
- Proposed standards should emphasize early palliative care integration.
- Resource allocation for training and multidisciplinary, cross-setting care (including home-based) is vital.
Abstract:
Children with non-curative brain tumors have a predictable and burdensome neurological decline. Care provision for these children falls in the gap where the acute inpatient services intersect with community-based providers. These children commonly receive care in the community; however, their neurological decline often outpaces engagement with community-based providers. Children with non-curative brain tumors are commonly referred to specialist palliative care services and need timely availability and access to this support. The purpose of this scoping review was to explore the evidence related to standards, guidelines, and models of palliative care provision for children with non-curative brain tumors, and to examine the facilitators and barriers to the implementation of, and access to, these services. Using a narrative synthesis method, a scoping review was conducted according to the Joanna Briggs Institute methodology using six electronic databases (Medline, Embase, Web of Science, Pubmed, CINAHL, and Cochrane Database of Systematic Reviews) from January 2013 to May 2023. A total of 2404 studies were screened for eligibility and 31 were selected for data extraction. There are no international models or standards of care for providing palliative care for children with non-curative brain tumors. Instead, palliative care is delivered at an institutional level, potentially leading to variability in the care that is provided. This variability can threaten the quality of life of these children and their families. Variability in care provision could be minimized by development of standardized palliative care provision. Any proposed standard for palliative care provision for children with non-curative brain tumors should include early integration of palliative care, and allocation of resources to enable training to operationalize referrals to palliative care teams and multidisciplinary care provision across settings, especially home-based care.
More Related Videos
07:39Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021
07:44Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
Published on: May 2, 2025
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Continuing Care
Tumor Immunotherapy